NSE · FORTIS
Fortis Healthcare Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹489 Cr with net profit ₹48 Cr — a 9.76% net margin, versus 11.35% the period before.
Shareholding
As of 2026-06-30
- Promoter31.17%
- Public11.4%
- FII25.2%
- DII32.23%
2,20,743 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.44× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #4 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,041 Cr | 60.38 | 13.48 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,02,830 Cr | 68.69 | 9.59 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹98,140 Cr | 104.64 | 5.98 | 10.59% | 7.81% |
| Fortis Healthcare Ltd.(this company) | ₹67,686 Cr | 63.45 | 6.82 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹65,493 Cr | 168.84 | 15.57 | 8.48% | 6.54% |
| Global Health Limited | ₹40,003 Cr | 69.88 | 10.1 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,487 Cr | 44.65 | 8.48 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,172 Cr | 158.91 | 8.86 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,056 Cr | 56.99 | 12.79 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,224 Cr | 53.82 | 5.55 | 10.37% | 15.77% |
AI analysis
AI-generated · google/gemini-2.5-flashFortis Healthcare Ltd. is listed with a market capitalization of Rs 71812 Cr. The company reported revenue of Rs 7849.69 Cr and a profit margin of 11.41%. Its earnings per share (EPS) stands at 14.03, with a return on equity (ROE) of 10.53% and return on capital employed (ROCE) of 12.56%.
Positives
- +Revenue grew by 12.9%.
- +Promoter shareholding pledge is 0% as of March 2026.
- +Debt-to-equity ratio at 0.22 is low.
Negatives
- −Promoter shareholding decreased from 52.3039% in March 2017 to 31.1667% in March 2026.
- −The trailing twelve months PE ratio of 270.23 is high relative to its EPS of 14.03.
Financial Performance
Fortis Healthcare Ltd. recorded a revenue of Rs 7849.69 Cr with a revenue growth of 12.9%. The net profit for the period Mar 2025 was Rs 774.2152 Cr. Quarterly revenue for Mar 2026 was Rs 2364.67 Cr, with a net profit of Rs 265.85 Cr. The company's EPS was 14.03, with a book value of Rs 131.07.
Profitability & Returns
The company achieved a profit margin of 11.41%. Return on equity (ROE) is reported at 10.53%, and return on capital employed (ROCE) is 12.56%. The earnings per share (EPS) for the company was 14.03. For the year ended Mar 2025, the EPS was 10.26.
Balance Sheet
Fortis Healthcare Ltd. has a debt-to-equity ratio of 0.22. The book value per share is Rs 131.07. No specific details about total assets or liabilities are provided in the available data.
Ownership & Pledges
As of Mar 2026, promoter shareholding in Fortis Healthcare Ltd. stood at 31.1667%, with institutional holding at 57.3259%. Foreign Institutional Investors (FIIs) held 25.972% and Domestic Institutional Investors (DIIs) held 31.3539%. Public shareholding was 11.5073%. The promoter pledge is 0% as of Mar 2026.
Data as of — price: 2026-09-23 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.